Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jun 16;45(7):NP139-NP141.
doi: 10.1093/asj/sjaf061.

Response to: Hyaluronidase Availability Beyond the Aesthetic Office: A Shared Responsibility for Safety in Filler Complications

Editorial

Response to: Hyaluronidase Availability Beyond the Aesthetic Office: A Shared Responsibility for Safety in Filler Complications

Greg J Goodman et al. Aesthet Surg J. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Currie E, Granata B, Goodman G, et al. The use of hyaluronidase in aesthetic practice: a comparative study of practitioner usage in elective and emergency situations. Aesthet Surg J. 2024;44:647–657. doi: 10.1093/asj/sjae009 - DOI - PMC - PubMed
    1. Zaki DP, Firriolo JM, Roohani I, Pu LLQ. Hyaluronidase availability beyond the aesthetic office: a shared responsibility for safety in filler complications. Aesthet Surg J. doi: 10.1093/asj/sjaf018. [Epub ahead of print] - DOI - PubMed
    1. Nikolis A, Cohen JL, Enright KM, et al. Deliberations of the safety task force: risk factors and treatment of adverse events associated with aesthetic injectables. J Cosmet Dermatol. 2024;23:3551–3564. doi: 10.1111/jocd.16476 - DOI - PubMed
    1. Goodman GJ, Magnusson MR, Callan P, et al. A consensus on minimizing the risk of hyaluronic acid embolic visual loss and suggestions for immediate bedside management. Aesthet Surg J. 2020;40:1009–1021. doi: 10.1093/asj/sjz312 - DOI - PMC - PubMed